$COSMJun 11, 2026, 1:35 PMAI processed
COSM gets 180-day Nasdaq extension to regain $1 bid-price compliance
AI Summary
Cosmos Health (NASDAQ: COSM) said Nasdaq granted an additional 180-day period, through Dec. 7, 2026, to regain compliance with the $1.00 minimum bid-price rule after Nasdaq found the company meets all other listing requirements. To cure the deficiency the stock must close at $1.00+ for 10 consecutive business days; the company says it prefers to restore compliance via business execution rather than a reverse stock split, which it would use only if necessary.
Positives
- Nasdaq granted a 180-day extension through Dec. 7, 2026 to regain $1 minimum bid compliance
- Nasdaq confirmed the company meets all other applicable listing requirements and the public float/market-value tests
- Company intends to pursue operational initiatives to raise share price and avoid a reverse split
Negatives
- COSM remains noncompliant with Nasdaq's $1.00 minimum bid requirement
- Must achieve a $1.00+ closing bid for 10 consecutive business days before the Dec. 7, 2026 deadline or face delisting risk
- Company may still effect a reverse stock split as a last resort to preserve listing